Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2018-05-02 2018-05-02
Drug Identification Number 02359472 02359472
Brand name MYLAN-DONEPEZIL MYLAN-DONEPEZIL
Common or Proper name DONEPEZIL DONEPEZIL
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients DONEPEZIL HYDROCHLORIDE DONEPEZIL HYDROCHLORIDE
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100BT 100BT
ATC code N06DA N06DA
ATC description ANTI-DEMENTIA DRUGS ANTI-DEMENTIA DRUGS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-05-01 2018-05-01
Actual discontinuation date 2018-05-01 2018-05-01
Remaining supply date 2018-05-01 2018-05-01
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Discontinued in shortage ID 9303. Last Lot # 8039450 and Expires 31-Jul-18 Discontinued in shortage ID 9303. Last Lot # 8039450 and Expires 31-Jul-18
Health Canada comments